Minicyclotron-based technology for the production of positron-emitting labelled radiopharmaceuticals [electronic resource].

Published:: Oak Ridge, Tenn. : Distributed by the Office of Scientific and Technical Information, U.S. Dept. of Energy, 1983.
Physical Description:: Pages: 21 : digital, PDF file
Additional Creators:: United States. Department of Energy. Office of Scientific and Technical Information

Access Online

www.osti.gov

Availability

Finding items...

Restrictions on Access:

Free-to-read Unrestricted online access

Summary:

The use of short-lived positron emitters such as carbon 11, fluorine 18, nitrogen 13, and oxygen 15, together with positron-emission tomography (PET) for probing the dynamics of physiological and biochemical processes in the normal and diseased states in man is presently an active area of research. One of the pivotal elements for the continued growth and success of PET is the routine delivery of the desired positron emitting labelled compounds. To date, the cyclotron remains the accelerator of choice for production of medically useful radionuclides. The development of the technology to bring the use of cyclotrons to a clinical setting is discussed. (ACR)

Report Numbers:

E 1.99:conf-8305109-1
conf-8305109-1

Subject(s):

Radiology And Nuclear Medicine

Other Subject(s):

Note:

Published through SciTech Connect.
01/01/1983.
"conf-8305109-1"
"DE83014732"
7. Nobel conference on positron emission tomography, Stockholm, Sweden, 17 May 1983.
MacDonald, N.S.; Satyamurthy, N.; Barrio, J.R.; Bida, G.; Phelps, M.E.; Padgett, H.C.
California Univ., Los Angeles (USA)

Funding Information:

AC03-76SF00012

View MARC record | catkey: 14387374